(19)
(11) EP 1 225 911 A1

(12)

(43) Date of publication:
31.07.2002 Bulletin 2002/31

(21) Application number: 00972133.3

(22) Date of filing: 13.10.2000
(51) International Patent Classification (IPC)7A61K 38/19
(86) International application number:
PCT/US0028/349
(87) International publication number:
WO 0126/676 (19.04.2001 Gazette 2001/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 14.10.1999 US 159362 P
08.11.1999 US 164059 P
23.12.1999 US 172063 P
14.03.2000 US 189048 P
24.04.2000 US 199142 P
13.06.2000 US 211458 P
19.06.2000 US 212658 P

(71) Applicant: Human Genome Sciences
Rockville,Maryland 20850 (US)

(72) Inventors:
  • GRZEGORZEWSKI, Krzysztof, J.
    Montgomery Village, MD 20879 (US)
  • ROSEN, Craig, A.
    Laytonsville, MD 20882 (US)
  • PATEL, Vikram
    Germantown, MD 20876 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) METHODS OF TREATING OR PREVENTING CELL, TISSUE, AND ORGAN DAMAGE USING HUMAN MYELOID PROGENITOR INHIBITORY FACTOR-1 (MPIF-1)